Sacituzumab for the treatment of triple-negative breast cancer: the poster child of future therapy?

Zangardi, Mark L

Sacituzumab for the treatment of triple-negative breast cancer: the poster child of future therapy? [electronic resource] - Expert opinion on investigational drugs Feb 2019 - 107-112 p. digital

Publication Type: Journal Article; Review

1744-7658

10.1080/13543784.2019.1555239 doi


Age Factors
Antibodies, Monoclonal, Humanized--administration & dosage
Antineoplastic Agents--administration & dosage
Camptothecin--administration & dosage
Female
Humans
Immunoconjugates--administration & dosage
Prognosis
Triple Negative Breast Neoplasms--drug therapy